Imprimis NJOF, LLC: Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46
Read the official notice at FDA (drug) →
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Imprimis NJOF, LLC
- Product
- Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
- Reason / hazard
- Presence of particulate matter - Glass like particles.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- U.S Nationwide
- Recall initiated
- 2025-12-18
- Code info
- Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.
- Product quantity
- 596 boxes of 11,920 pre-filled syringes
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Ledgewood
- State
- NJ
- Country
- United States
- Event id
- 98181
Free daily digest + "My products" watchlist